Characterization of protein therapeutics using mass spectrometry
Protein therapeutics high efficacy, safety, and ability to treat life-threatening diseases such as cancer, inflammation and genetic disorders have revolutionized modern medicine. In 2012, 200 companies competed in this
Wedi'i Gadw mewn:
| Awduron Eraill: | |
|---|---|
| Fformat: | Livre numérique |
| Iaith: | Anglais |
| Cyhoeddwyd: |
New York, NY :
Springer US
[20..].
Cham : Springer Nature |
| Rhifyn: | 1st ed. 2013. |
| Mynediad Ar-lein: | Accès sur la plateforme de l'éditeur Accès sur la plateforme Istex Accès Université d'Orléans Accès INSA CVL |
| Nodyn: |
Archives Springer e-books (Licence nationale) Archives Springer e-books (Licence nationale) |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Characterization of Protein Therapeutics using Mass Spectrometry, Texte imprimé, 9781441978615 |
| LEADER | 02975nam a22003257a 4500 | ||
|---|---|---|---|
| 001 | 946420 | ||
| 008 | 130704q2000 xx ||| |||| 00| 0 eng d | ||
| 009 | PPN170486753 | ||
| 020 | |a 9781441978622 | ||
| 020 | |a 9781441978622 | ||
| 041 | 0 | |a eng | |
| 082 | |a 543.65 | ||
| 245 | 0 | 0 | |a Characterization of protein therapeutics using mass spectrometry |c edited by Guodong Chen. |
| 250 | |a 1st ed. 2013. | ||
| 260 | |a New York, NY : |b Springer US. | ||
| 260 | |a Cham : |b Springer Nature, |c [20..]. | ||
| 500 | |a Archives Springer e-books (Licence nationale) | ||
| 500 | |a Archives Springer e-books (Licence nationale) | ||
| 505 | 1 | |a Characterization of Protein Therapeutics by Mass Spectrometry: Recent Developments and Future Directions The Use of Mass Spectrometry to Characterize the Metabolism of Peptide Therapeutics Quantitative Analysis of Biologics Using Mass Spectrometry Maximizing Structural Information from Whole Protein Tandem Mass Spectrometry Disulfide Linkages of an Albumin Fusion Protein Detailed Structural Characterization of Monoclonal Antibodies Application of Protein Mass Spectrometry in Impurity and Degradant Characterization Mass Spectrometry Methods to Analyze Higher Order Structure of Protein Therapeutics by Chemical Footprinting Aglycosylations Alters Protein Conformation in Antibodies Engineered with Specific Effector Functions Using HDX-MS Characterizing Biotherapeutic Protein 3D Structures by Electrospray Ion-Mobility Mass Spectrometry Oxford University, Characterization of Assemblies of Proteins by Mass Spectrometry | |
| 506 | |a Accès en ligne pour les établissements français bénéficiaires des licences nationales | ||
| 506 | |a Accès soumis à abonnement pour tout autre établissement | ||
| 506 | |a Conditions particulières de réutilisation pour les bénéficiaires des licences nationales. https://www.licencesnationales.fr/springer-nature-ebooks-contrat-licence-ln-2017 | ||
| 520 | |a Protein therapeutics high efficacy, safety, and ability to treat life-threatening diseases such as cancer, inflammation and genetic disorders have revolutionized modern medicine. In 2012, 200 companies competed in this | ||
| 700 | 1 | |a Chen, Guodong, |d 19..-...., |c chimiste. |4 pbd | |
| 776 | 0 | |t Characterization of Protein Therapeutics using Mass Spectrometry |b Texte imprimé |z 9781441978615 | |
| 856 | 4 | |q PDF |u https://doi.org/10.1007/978-1-4419-7862-2 |z Accès sur la plateforme de l'éditeur | |
| 856 | 4 | |u https://revue-sommaire.istex.fr/ark:/67375/8Q1-VL9W49X1-3 |z Accès sur la plateforme Istex | |
| 856 | 4 | |5 452349901:747840377 |u https://ezproxy.univ-orleans.fr/login?url=https://dx.doi.org/10.1007/978-1-4419-7862-2 |z Accès Université d'Orléans | |
| 856 | 4 | |5 180339901:750857862 |u https://ezproxy.insa-cvl.fr/login?qurl=https://dx.doi.org/10.1007/978-1-4419-7862-2 |z Accès INSA CVL | |
| 997 | |0 946420 |1 Livre numérique |a Ressource numérique |b INSA |b ENSA |c 0/Bibliothèque numérique/ |c 1/Bibliothèque numérique/Autre ressource numérique/ | ||